Gan & Lee Pharmaceuticals Announced Positive Phase 1 Results for Its Oral GLP-1 Receptor Agonist GZR18 Tablet in Healthy Participants, Demonstrating 4.16% Weight Reduction in Two Weeks

After two weeks of treatment, GZR18 tablets resulted in an average weight…

Trump Victory: Vietnam To Actively Seek Neutral Stance

Key View Trump’s victory will cast a shadow on Vietnam’s export-driven growth…

2024 Tsingke High-Impact Literature Compilation – Gene Synthesis

BEIJING, Nov. 12, 2024 /PRNewswire/ — Tsingke has delivered high-quality biotechnology services and…

deCODE genetics/Amgen: New Study Explores the Role of BMI in Disease Risk

REYKJAVIK, Iceland, Nov. 12, 2024 /PRNewswire/ — New study from deCODE genetics/Amgen highlights…

CBAK Energy Reports Third Quarter & First Nine Months of 2024 Unaudited Financial Results

DALIAN, China, Nov. 12, 2024 /PRNewswire/ — CBAK Energy Technology, Inc. (NASDAQ:…

HUYA Inc. Reports Third Quarter 2024 Unaudited Financial Results

GUANGZHOU, China, Nov. 12, 2024 /PRNewswire/ — HUYA Inc. ("Huya" or the…

MALAYSIA STRENGTHENS SUSTAINABILITY FOOTHOLD AT COP29 AS COUNTRY ASSUMES ASEAN CHAIR IN 2025

The Malaysia Pavilion at COP29 showcases the nation’s commitment to achieve net-zero…

HKBNES Partners with Mainland China's Leading Disaster Recovery Vendor Information2 Software to Transform Enterprise Customer Resilience

HONG KONG, Nov. 12, 2024 /PRNewswire/ — HKBN Enterprise Solutions (HKBNES) has…